Picture of Aldeyra Therapeutics logo

ALDX Aldeyra Therapeutics Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Aldeyra Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments73.477.9230174143
Prepaid Expenses
Total Current Assets75.283.1233181148
Net Property, Plant And Equipment0.3490.2930.3840.2690.517
Other Long Term Assets
Total Assets75.583.4233181148
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities12.912.411.815.422.3
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities27.423.827.430.328.5
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity48.159.5206151120
Total Liabilities & Shareholders' Equity75.583.4233181148
Total Common Shares Outstanding